Drugs / CKD-348 T1
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT04304547 Comparator | Feb → Apr 2020 | — | Chong Kun Dang Pharmaceutical | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CKD-348 T1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04304547 ↗ |
| Route | Oral | “CKD-348 T1 1 tablet” NCT04304547 ↗ |